Friday, November 15, 2024
Home 2023

Yearly Archives: 2023

Biotech News

Adial (ADIL). Don’t Give up Drinking. Just Drink Less!

Editor / Curator -
Biotech News

Citius Pharma (CTXR) to Merge Subsidiary, with Publicly Traded SPAC TenX...

Editor / Curator -
2023 Watch List

Ardelyx (ARDX) $3.40, Receives FDA Approval.

Editor / Curator -
Hollywood Stock Review
Hollywood Stock Review

Adding Dolphin Entertainment (DLPN) to the Watch List

Editor / Curator -
All News

Adding Paramount (PARA) $12 to the Watch List.

Editor / Curator -
Marijuana Stock Review

Vext Science and Cannabis (VEXTF) Sells Prescott Cultivation Facility for $6.5...

Editor / Curator -
All News

Thumzup Media (TZUP) Ascends to Top 6.3% of All Active Reg...

Editor / Curator -
All News

Yuengling (YCRM) and PickleJar Announce Update to Complete Proposed Business Combination.

Editor / Curator -
Internet News

EyeOnChannel Production Studio & Network

Editor / Curator -
Conferences

Top Presenters, Dawson James 8th Annual Investor Conference.

Editor / Curator -
1...456...18Page 5 of 18

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.